US3342824A
(en)
*
|
1964-12-07 |
1967-09-19 |
Lilly Co Eli |
Normorphines
|
GB1123768A
(en)
*
|
1966-07-29 |
1968-08-14 |
Smith Kline French Lab |
New thebaine and oripavine derivatives and processes for preparing the same
|
US3466277A
(en)
*
|
1966-12-13 |
1969-09-09 |
Boehringer Sohn Ingelheim |
N-allylic cyclohexyl lower alkyl normorphines
|
US3905981A
(en)
*
|
1973-10-12 |
1975-09-16 |
Research Corp |
N-dealkylation of tertiary amines
|
NO802139L
(no)
*
|
1979-08-09 |
1981-02-10 |
Mallinckrodt Inc |
Utgangsforbindelser for fremstilling av morfinderivater, samt fremgangsmaate til fremstilling av utgangsforbindelsene
|
US4613668A
(en)
*
|
1983-12-22 |
1986-09-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Short total synthesis or morphinan compounds which uses cyclization of a cycloalkylcarbonyl compound selected from cyclopropylcarbonyl and cyclobutylcarbonyl
|
US4990617A
(en)
*
|
1985-12-02 |
1991-02-05 |
E. I. Du Pont De Nemours And Company |
N-oxide prodrug derivatives of 3-hydroxy morphinans and partial morphinans and derivatives
|
US4722928A
(en)
*
|
1985-12-02 |
1988-02-02 |
E. I. Du Pont De Nemours And Company |
N-oxide prodrug derivatives of 3-hydroxy morphinans and partial morphinans having improved oral bioavailability, pharmaceutical compositions, and processes
|
US5668285A
(en)
*
|
1986-10-31 |
1997-09-16 |
The United States Of America As Represented By The Department Of Health And Human Services |
Total synthesis of northebaine, normophine, noroxymorphone enantiomers and derivatives via N-Nor intermediates
|
JP2694156B2
(ja)
*
|
1989-10-16 |
1997-12-24 |
アメリカ合衆国 |
N−ノル中間体を介するノルテバイン、ノルモルフィン、ノルオキシモルフォン鏡像異性体の全合成
|
US5028612A
(en)
*
|
1990-03-22 |
1991-07-02 |
Hillel Glover |
Method for treating emotional numbness
|
DE602004024963D1
(de)
*
|
2003-03-13 |
2010-02-25 |
Controlled Chemicals Inc |
Oxycodon- konjugate mit niedrigerem missbrauch- potential und ausgedehnter tätigkeitsdauer
|
EP1782834A3
(en)
*
|
2003-03-13 |
2007-08-01 |
Controlled Chemicals, Inc. |
Oxycodone conjugates with lower abuse potential and extended duration of action
|
ATE493417T1
(de)
*
|
2005-06-16 |
2011-01-15 |
Mallinckrodt Inc |
Synthetische route zu 14-hydroxylopiaten über 1- halogenthebain oder analoga
|
BRPI0719305A2
(pt)
*
|
2006-11-22 |
2014-02-04 |
Progenics Pharm Inc |
(r)-n-estereoisômeros de análogos de 7,8-saturados-4,5-epóxi-morfinano
|
EP2125824B2
(en)
*
|
2007-03-23 |
2023-11-15 |
Mallinckrodt LLC |
Improved preparation of oxymorphone from oripavine
|
CN101711236B
(zh)
|
2007-04-12 |
2012-10-31 |
Nsab神经研究瑞典公司分公司 |
表现出改善的心血管副作用特性的多巴胺受体稳定剂/调节剂的n-氧化物和/或二-n-氧化物衍生物
|
JP5373764B2
(ja)
*
|
2007-04-16 |
2013-12-18 |
マリンクロッド エルエルシー |
触媒性水素転移反応を使用する新規なオピエート還元
|
US7671204B2
(en)
*
|
2007-12-17 |
2010-03-02 |
Mallinckrodt Inc. |
N-demethylation of N-methyl morphinans
|
ES2455718T3
(es)
*
|
2007-12-17 |
2014-04-16 |
Mallinckrodt Llc |
Procedimiento y compuestos para la producción de (+) opiáceos
|
WO2010039209A2
(en)
*
|
2008-09-30 |
2010-04-08 |
Mallinckrodt Inc. |
Processes for the synthesis of tertiary amines
|
US8623888B2
(en)
*
|
2009-07-15 |
2014-01-07 |
Mallinckrodt Llc |
3-oxy-hydromorphone derivatives
|